Literature DB >> 12614226

Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry.

Ernest Beutler1, Vincent Felitti, Terri Gelbart, Jill Waalen.   

Abstract

High frequencies of the C282Y and H63D mutations of the HFE gene occur in European populations, even though homozygous and compound heterozygous states are associated with hereditary haemochromatosis, which is a disease that decreases fitness. This suggests that heterozygotes may possess a selective advantage. HFE mutations increase iron absorption in patients with haemochromatosis, and the mean transferrin saturations and ferritin levels are mildly increased in heterozygotes, suggesting that HFE mutations may protect against iron depletion and iron deficiency anaemia. In this study of 23,681 Caucasian adults, mean transferrin saturation, serum ferritin and haemoglobin levels were significantly higher in subjects carrying HFE mutations compared with wild types. Analysed by ethnicity, mean haemoglobin and mean erythrocyte volume (MCV) were significantly lower in those with a southern versus northern European ancestry. C282Y mutation carriers had an increased mean haemoglobin level in both ethnic groups. Prevalence of non-anaemic iron deficiency was significantly lower among female carriers of the C282Y mutation compared with HFE wild types. However, prevalence of frank iron deficiency anaemia did not differ significantly among genotypes. Quantile:quantile plots showed a small but significant upward shift in the mid-range of the haemoglobin distribution among C282Y mutation carriers that was consistent with an increased mean haemoglobin level without significant changes in the anaemic range.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614226     DOI: 10.1046/j.1365-2141.2003.04215.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  25 in total

1.  The origin and spread of the HFE-C282Y haemochromatosis mutation.

Authors:  S Distante; K J H Robson; J Graham-Campbell; A Arnaiz-Villena; P Brissot; Mark Worwood
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

2.  Serum ferritin and erythrocyte indices in iron overload.

Authors:  Gemino Fiorelli
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

3.  Serum ferritin levels correlate with haemoglobin concentration: a report on 589 outpatients from a single centre.

Authors:  Massimo Franchini; Gian Luca Salvagno; Martina Montagnana; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 4.  Laboratory and genetic assessment of iron deficiency in blood donors.

Authors:  Joseph E Kiss
Journal:  Clin Lab Med       Date:  2014-11-05       Impact factor: 1.935

Review 5.  The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?

Authors:  Ernest Beutler; Jill Waalen
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

6.  Iron genes, iron load and risk of Alzheimer's disease.

Authors:  D J Lehmann; M Worwood; R Ellis; V L J Wimhurst; A T Merryweather-Clarke; D R Warden; A D Smith; K J H Robson
Journal:  J Med Genet       Date:  2006-10       Impact factor: 6.318

7.  The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation*.

Authors:  Alan E Mast; Tzong-Hae Lee; Karen S Schlumpf; David J Wright; Bryce Johnson; Danielle M Carrick; Ritchard G Cable; Joseph E Kiss; Simone A Glynn; Whitney R Steele; Edward L Murphy; Ronald Sacher; Michael P Busch
Journal:  Br J Haematol       Date:  2011-11-25       Impact factor: 6.998

8.  Genome-wide association study of serum iron phenotypes in premenopausal women of European descent.

Authors:  Daniel L Koller; Erik A Imel; Dongbing Lai; Leah R Padgett; Dena Acton; Amie Gray; Munro Peacock; Michael J Econs; Tatiana Foroud
Journal:  Blood Cells Mol Dis       Date:  2015-12-03       Impact factor: 3.039

9.  HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  James S Pankow; Eric Boerwinkle; Paul C Adams; Eliseo Guallar; Catherine Leiendecker-Foster; Jason Rogowski; John H Eckfeldt
Journal:  Transl Res       Date:  2008-06-13       Impact factor: 7.012

10.  Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels.

Authors:  John C Chambers; Weihua Zhang; Yun Li; Joban Sehmi; Mark N Wass; Delilah Zabaneh; Clive Hoggart; Henry Bayele; Mark I McCarthy; Leena Peltonen; Nelson B Freimer; Surjit K Srai; Patrick H Maxwell; Michael J E Sternberg; Aimo Ruokonen; Gonçalo Abecasis; Marjo-Riitta Jarvelin; James Scott; Paul Elliott; Jaspal S Kooner
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.